| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44027052 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44027053 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44027054 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44003695 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44003983 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44030487 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44006599 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44032977 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44017690 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
| TVIS44017691 | HTLV-1 | ENSG00000129521.15 | protein_coding | EGLN3 | No | No | 112399 | F8W1G2 Q3T1B0 Q9H6Z9 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | EGLN3 |
|---|---|
| DrugBank ID | DB04847 |
| Drug Name | Roxadustat |
| Target ID | BE0002219 |
| UniProt ID | Q9H6Z9 |
| Regulation Type | inhibitor |
| PubMed IDs | 30805897 |
| Citations | Dhillon S: Roxadustat: First Global Approval. Drugs. 2019 Apr;79(5):563-572. doi: 10.1007/s40265-019-01077-1. |
| Groups | Approved; Investigational |
| Direct Classification | N-acyl-alpha amino acids |
| SMILES | CC1=NC(C(=O)NCC(O)=O)=C(O)C2=C1C=C(OC1=CC=CC=C1)C=C2 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL2338329 |
